Fundamental Analysis
63 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +6.4% | +119.4% | 3 / 3 | +52.7% | -1.16 pp | -0.71 pp | +2.2% | 0.01 | 15.00 | 286 | +52,7% | 4,3 | +4,0% | 15.00 | 26.62 | −43,7% |
| Pts | 0 | 12 | 12 | 12 | 4 | 4 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 9.340 (close price on 2026-10-19)EPS (TTM): 622,8
Financial charts
1.Revenue & growth
VND bn287Q2/26
1.Revenue & growth
VND bn287Q2/26
2.Profit & growth
VND bn3,70Q2/26
3.Profit mix (Penman)
VND bn20,9Q2/26
4.Margins & cost structure
%21.2%Q2/26
5.Returns & cash cycle
% · days2.9%Q2/26
6.Earnings quality & cash
VND bn35,1Q2/26
7.Asset structure
VND bn1.134Q2/26
8.Funding & debt health
VND bn · times1.134Q2/26
9.Revenue backlog
VND bn26,6Q2/26
10.Valuation
times · %15,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %108Q2/26
Adjusted EPS growth, latest quarter
-2.6%
Average adjusted EPS growth, 3 quarters
124%
averaged over 2 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26